Core Viewpoint - The lawsuit against Xilong Science Co., Ltd. has progressed, with investors winning the final judgment and receiving compensation, while the company shows willingness to mediate [1][2]. Group 1: Legal Developments - Investors represented by Zhao Jingguo's legal team have achieved a final victory in their lawsuit against Xilong Science, with compensation awarded [1][2]. - The company received a notice of investigation from the China Securities Regulatory Commission (CSRC) on May 6, 2023, due to suspected violations of information disclosure laws [1][4]. - On July 7, 2023, Xilong Science was issued an administrative penalty decision by the CSRC, confirming that the company inflated revenue by fabricating trade activities involving ethylene glycol and methanol [1][4]. Group 2: Investor Compensation Conditions - Investors who purchased and held shares of Xilong Science between April 29, 2021, and April 28, 2023, are eligible to register for compensation, regardless of whether they sold their shares after April 29, 2023 [3][5]. - The specific compensation range will be determined by the court [5].
终审胜诉+调解!002584股票索赔案件仍在进行中